glp-1/gip vs tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Personalized Compounded Tirzepatide Treatment

It is advisable to follow these guidelines for optimal outcomes

You monitor every sensation, research side effects before bed, and lie awake wondering if each twitch is normal

However, more recent research provides a somewhat reassuring picture for short-to-medium term use

This can lead to a condition called telogen effluvium, where hair follicles enter into the telogen (resting) phase of their growth cycle prematurely and end up shedding the hair itself

Monitoring includes regular assessment of weight, vital signs, medication tolerance, complete blood count, comprehensive metabolic panel, renal function, and nutritional parameters including vitamin B12, folate, iron, vitamin D, calcium, and protein status

doi: 10.1177/00220345231151692 116 LiY